posted
I should of posted this days ago but check out GTCB. It has been green the last few days as Friday approaches as well as there FDA date of Feb 7th. Read below...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--The US Food and Drug Administration, or FDA, has accepted for review GTC Biotherapeutics, Inc.’s ("GTC", Nasdaq: GTCB) Biologics License Application, or BLA, for ATryn®. FDA’s Blood Products Advisory Committee intends to review the BLA for ATryn® during a meeting that is being planned for January 2009. Based on the achievement of these milestones, GTC has received $2 million in additional milestone payments from OVATION Pharmaceuticals, Inc.
As previously announced, ATryn® has been designated an Orphan Drug and FDA has determined that the product fulfills the criteria for Fast Track status. The ATryn® BLA will also receive Priority Review. Priority Review is granted to only to those products that, if approved, would provide a significant improvement in the safety or effectiveness of the treatment, diagnosis or prevention of a serious or life-threatening disease. Under Priority Review, the target date for FDA action on the BLA is February 7, 2009. This action date was affirmed by the FDA following preliminary review of the BLA performed in accepting the BLA.
IP: Logged |
posted
FDA Committee backs drug. Watch this Monday pre market. Feb 7th is D- Day though. Get in early before you miss the boat. I got in (second time around) early this week at .65. Will sell Monday morning for a nice gain then go back a third time before FDA Approval comes.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
